Sparse whole-genome sequencing identifies two loci for major depressive disorder

scientific article

Sparse whole-genome sequencing identifies two loci for major depressive disorder is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043277637
P356DOI10.1038/NATURE14659
P3181OpenCitations bibliographic resource ID891990
P932PMC publication ID4522619
P698PubMed publication ID26176920
P5875ResearchGate publication ID280081621

P2860cites workAn integrated map of genetic variation from 1,092 human genomesQ22122153
Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clusteringQ24655574
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
The genetics of major depressionQ26830784
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataQ27860742
The Sequence Alignment/Map format and SAMtoolsQ27860966
Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence readsQ28296838
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alphaQ28513388
A mega-analysis of genome-wide association studies for major depressive disorderQ29417093
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)Q29547223
LocusZoom: regional visualization of genome-wide association scan resultsQ29614868
Molecular signatures of major depressionQ30412070
The epidemiology of depression across culturesQ33908984
Genetic epidemiology of major depression: review and meta-analysisQ33919509
Power and predictive accuracy of polygenic risk scores.Q34337027
Further improvements to linear mixed models for genome-wide association studiesQ34504804
An integrative variant analysis pipeline for accurate genotype/haplotype inference in population NGS dataQ34538741
A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese womenQ36195814
The epidemiology of depression in metropolitan China.Q37189893
Low prevalence of major depressive disorder in Taiwanese adults: possible explanations and implications.Q40005640
Extremely low-coverage sequencing and imputation increases power for genome-wide association studiesQ41882858
Low-coverage sequencing: implications for design of complex trait association studiesQ42596059
Genetic and environmental risk factors for depression assessed by subject-rated symptom check list versus structured clinical interviewQ44884819
Clinical indices of familial depression in the Swedish Twin RegistryQ44927127
The diagnostic validity of melancholic major depression in a population-based sample of female twinsQ45103929
FaST linear mixed models for genome-wide association studiesQ46661213
Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality.Q51907241
P433issue7562
P407language of work or nameEnglishQ1860
P921main subjectwhole genome sequencingQ2068526
major depressive disorderQ42844
P304page(s)588-91
P577publication date2015-07-30
P1433published inNatureQ180445
P1476titleSparse whole-genome sequencing identifies two loci for major depressive disorder
P478volume523

Reverse relations

cites work (P2860)
Q37603810A Combined Pathway and Regional Heritability Analysis Indicates NETRIN1 Pathway Is Associated With Major Depressive Disorder
Q98735787A Comprehensive Analysis of the Effect of SIRT1 Variation on the Risk of Schizophrenia and Depressive Symptoms
Q57822446A Longitudinal Model of Human Neuronal Differentiation for Functional Investigation of Schizophrenia Polygenic Risk
Q38783177A continuum of genetic liability for minor and major depression.
Q38916885A current snapshot of common genomic variants contribution in psychiatric disorders
Q95319271A genome-wide association study of interhemispheric theta EEG coherence: implications for neural connectivity and alcohol use behavior
Q91359223A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder
Q36373005A latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohort
Q38776510A method for the allocation of sequencing resources in genotyped livestock populations
Q36306020A novel strategy for clustering major depression individuals using whole-genome sequencing variant data
Q40283480A rare missense variant in RCL1 segregates with depression in extended families
Q33553419A reference panel of 64,976 haplotypes for genotype imputation
Q91583047ADHD and depression: investigating a causal explanation
Q37102021Additive genetic risk from five serotonin system polymorphisms interacts with interpersonal stress to predict depression
Q47606495Advancing psychiatric genetics through dissecting heterogeneity
Q33885379Age of onset and family history as indicators of polygenic risk for major depression.
Q50072499Alcohol Misuse Across the Lifespan: Insights from Developmental Studies in Behavior Genetics.
Q60920695Allele Frequencies in Depressed Patients of European Descent in Russia
Q51761638Altered DNA methylation associated with a translocation linked to major mental illness.
Q40397660An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype
Q39186841An astroglial basis of major depressive disorder? An overview.
Q33791821An examination of the etiologic overlap between the genetic and environmental influences on insomnia and common psychopathology
Q50032095An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction.
Q48128009An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome
Q38626082Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry
Q92185935Analysis of polygenic risk score usage and performance in diverse human populations
Q92242987Analyzing the genes and pathways related to major depressive disorder via a systems biology approach
Q38931373Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders.
Q33635647Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.
Q91693285Association Analysis of 14 Candidate Gene Polymorphism with Depression and Stress among Gestational Diabetes Mellitus
Q47380198Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort.
Q61849573Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population.
Q93002221Association of SYNE1 locus with bipolar disorder in Chinese population
Q57515292Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank
Q64298943Association of a Schizophrenia-Risk Nonsynonymous Variant With Putamen Volume in Adolescents: A Voxelwise and Genome-Wide Association Study
Q30363301Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank
Q38837222Associations Between Dopamine D2 Receptor (DRD2) Gene, Maternal Positive Parenting and Trajectories of Depressive Symptoms from Early to Mid-Adolescence
Q64239350Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling
Q40170492BDNFVal66met polymorphism: a potential bridge between depression and thrombosis
Q57143143BK channel deacetylation by SIRT1 in dentate gyrus regulates anxiety and response to stress
Q93050179Bibliography: Depression: Challenges and Treatments
Q60643583Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression
Q91773699Brain Banks Spur New Frontiers in Neuropsychiatric Research and Strategies for Analysis and Validation
Q48067509Brain-derived neurotrophic factor Val66Met polymorphism in depression and thrombosis: SIRT1 as a possible mediator
Q94562501Brain-specific Wt1 deletion leads to depressive-like behaviors in mice via the recruitment of Tet2 to modulate Epo expression
Q39825160CHRONICITY OF DEPRESSION AND MOLECULAR MARKERS IN A LARGE SAMPLE OF HAN CHINESE WOMEN.
Q59068655China’s crackdown on genetics breaches could deter data sharing
Q53668059Cognitive genomics: Linking genes to behavior in the human brain.
Q38863541Common Genetic Variation Near Melatonin Receptor 1A Gene Linked to Job-Related Exhaustion in Shift Workers
Q47334914Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders.
Q39710652Common variants in CACNA1C and MDD susceptibility: A comprehensive meta-analysis.
Q37236662Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis
Q57316757Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder
Q91330217Comparative genetic architectures of schizophrenia in East Asian and European populations
Q35804142Comparative genome-wide association studies of a depressive symptom phenotype in a repeated measures setting by race/ethnicity in the Multi-Ethnic Study of Atherosclerosis
Q91585548Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese
Q60632104Continuity of genetic and environmental influences on clinically assessed major depression from ages 18 to 45
Q90575529Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry
Q57697817Convergence of evidence from a methylome-wide CpG-SNP association study and GWAS of major depressive disorder
Q47389484Copy number variation meta-analysis reveals a novel duplication at 9p24 associated with multiple neurodevelopmental disorders
Q56337964Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression
Q56992616DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies
Q36485741DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder
Q61443156DNA methylation in the human frontal cortex reveals a putative mechanism for age-by-disease interactions
Q30400681DSM disorders and their criteria: how should they inter-relate?
Q92555462Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders
Q58617330Depression
Q49912400Depression and obesity: evidence of shared biological mechanisms.
Q90182946Depression genetic risk score is associated with anhedonia-related markers across units of analysis
Q92621397Development and challenges of mental health in China
Q30235350Development of depression in survivors of childhood and adolescent cancer: a multi-level life course conceptual framework.
Q90304075Differential associations of depression-related phenotypes with cardiometabolic risks: Polygenic analyses and exploring shared genetic variants and pathways
Q36559255Disease and Polygenic Architecture: Avoid Trio Design and Appropriately Account for Unscreened Control Subjects for Common Disease
Q38623862Do regional brain volumes and major depressive disorder share genetic architecture? A study of Generation Scotland (n=19 762), UK Biobank (n=24 048) and the English Longitudinal Study of Ageing (n=5766).
Q46643230Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium
Q47264713Drp1 Mitochondrial Fission in D1 Neurons Mediates Behavioral and Cellular Plasticity during Early Cocaine Abstinence
Q38804179EBT: A Statistic Test Identifying Moderate Size of Significant Features with Balanced Power and Precision for Genome-wide Rate Comparisons
Q48065412Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample
Q92759312Effects of the LHPP gene polymorphism on the functional and structural changes of gray matter in major depressive disorder
Q104795298Efficient phasing and imputation of low-coverage sequencing data using large reference panels
Q37611719Emerging Molecular Pathways Governing Dietary Regulation of Neural Stem Cells during Aging.
Q31108294Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set
Q47572896Epigenetic mechanisms of major depression: Targeting neuronal plasticity.
Q41573772Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides
Q42705159Estimation of kinship coefficient in structured and admixed populations using sparse sequencing data.
Q38917988Evidence of AS3MTd2d3-Associated Variants within 10q24.32-33 in the Genetic Risk of Major Affective Disorders
Q63728363Evidence of causal effect of major depression on alcohol dependence: findings from the psychiatric genomics consortium
Q39588010Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms.
Q38668022Expert and self-assessment of lifetime symptoms and diagnosis of major depressive disorder in large-scale genetic studies in the general population: comparison of a clinical interview and a self-administered checklist
Q41951157Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.
Q39033094Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits
Q33716821Extremely low-coverage whole genome sequencing in South Asians captures population genomics information
Q37048022Fast and accurate long-range phasing in a UK Biobank cohort
Q64917597Finding associated variants in genome-wide association studies on multiple traits.
Q48078284First robust genetic links to depression emerge
Q54966377From the Psychiatrist's Couch to Induced Pluripotent Stem Cells: Bipolar Disease in a Dish.
Q89581678Further Evidence of an Association between NCAN rs1064395 and Bipolar Disorder
Q90408062Further confirmation of netrin 1 receptor (DCC) as a depression risk gene via integrations of multi-omics data
Q36782711GENOME-WIDE ASSOCIATION STUDY (GWAS) AND GENOME-WIDE BY ENVIRONMENT INTERACTION STUDY (GWEIS) OF DEPRESSIVE SYMPTOMS IN AFRICAN AMERICAN AND HISPANIC/LATINA WOMEN.
Q38904425GW-SEM: A Statistical Package to Conduct Genome-Wide Structural Equation Modeling
Q57159613GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort
Q36542410GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person
Q38600696Gene × Environment Determinants of Stress- and Anxiety-Related Disorders
Q58786918Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)
Q38728415Genetic Approaches to Understanding Psychiatric Disease.
Q36404519Genetic Control over mtDNA and Its Relationship to Major Depressive Disorder
Q57077043Genetic Overlap Between Depression and Cardiometabolic Disorders
Q28072645Genetic Pathways to Insomnia
Q42699257Genetic Risk Variants Associated With Comorbid Alcohol Dependence and Major Depression.
Q38924066Genetic Studies on the Tripartite Glutamate Synapse in the Pathophysiology and Therapeutics of Mood Disorders.
Q37249137Genetic and Environmental Factors Associated with Cannabis Involvement
Q37339747Genetic and environmental components of female depression as a function of the severity of the disorder
Q38961848Genetic and environmental influences on last-year major depression in adulthood: a highly heritable stable liability but strong environmental effects on 1-year prevalence
Q58797784Genetic association and meta-analysis of a schizophrenia GWAS variant rs10489202 in East Asian populations
Q33601878Genetic effects influencing risk for major depressive disorder in China and Europe
Q61807449Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms
Q38769614Genetic epidemiology of migraine and depression
Q90146410Genetic heterogeneity in self-reported depressive symptoms identified through genetic analyses of the PHQ-9
Q47903939Genetic risk mechanisms of posttraumatic stress disorder in the human brain
Q90431881Genetic stratification of depression by neuroticism: revisiting a diagnostic tradition
Q38883299Genetic susceptibility to bilateral tinnitus in a Swedish twin cohort.
Q91928661Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm
Q36429824Genetical Genomics of Behavior: A Novel Chicken Genomic Model for Anxiety Behavior
Q33840955Genetics of Depression: Progress at Last
Q28072284Genetics of Tinnitus: An Emerging Area for Molecular Diagnosis and Drug Development
Q41585015Genetics of disease: Associations with depression
Q57041595Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect
Q37603806Genome-wide Association for Major Depression Through Age at Onset Stratification: Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Q40353484Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder
Q36932866Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci.
Q52560096Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Q33703868Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus
Q47745726Genome-wide association studies of bipolar disorder: A systematic review of recent findings and their clinical implications.
Q61805770Genome-wide association study identifies a novel locus associated with psychological distress in the Japanese population
Q57032352Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression
Q36067406Genome-wide association study of behavioral, physiological and gene expression traits in outbred CFW mice
Q52584632Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways.
Q52367035Genome-wide association study of depressive symptoms in the Hispanic Community Health Study/Study of Latinos.
Q39783086Genome-wide association study of generalized anxiety symptoms in the Hispanic Community Health Study/Study of Latinos
Q40367486Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.
Q46022556Genome-wide gene-environment interaction in depression: A systematic evaluation of candidate genes: The childhood trauma working-group of PGC-MDD.
Q47394982Genome-wide haplotype-based association analysis of major depressive disorder in Generation Scotland and UK Biobank.
Q60641775Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder
Q28384381Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression
Q47556039Genome-wide meta-analyses of stratified depression in Generation Scotland and UK Biobank.
Q63433067Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions
Q50421669Genome-wide scan of depressive symptomatology in two representative cohorts in the United States and the United Kingdom.
Q49822467Genomewide association study of alcohol dependence and related traits in a Thai population.
Q37735446Genomic Rearrangements in Arabidopsis Considered as Quantitative Traits
Q90975802Genomic prediction of depression risk and resilience under stress
Q58609986HPA-axis multilocus genetic variation moderates associations between environmental stress and depressive symptoms among adolescents
Q47407332Heritability of major depressive and comorbid anxiety disorders in multi-generational families at high risk for depression
Q38611730Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence.
Q40097401High-Coverage Whole-Exome Sequencing Identifies Candidate Genes for Suicide in Victims with Major Depressive Disorder.
Q38681922Histone Modifications in Major Depressive Disorder and Related Rodent Models.
Q93077297How genome-wide association studies (GWAS) made traditional candidate gene studies obsolete
Q38850402Human Genomic Signatures of Brain Oscillations During Memory Encoding
Q47174305Huntingtin gene repeat size variations affect risk of lifetime depression
Q54978040Identification and bioinformatics analysis of overlapping differentially expressed genes in depression, papillary thyroid cancer and uterine fibroids.
Q39537609Identification of 15 genetic loci associated with risk of major depression in individuals of European descent.
Q57677495Identification of expression quantitative trait loci associated with schizophrenia and affective disorders in normal brain tissue
Q64094594Identification of key genes, pathways, and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis
Q38664301Identifying and mitigating batch effects in whole genome sequencing data.
Q36304801Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential
Q56768819Imaging genetics paradigms in depression research: Systematic review and meta-analysis
Q37642670Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder
Q41548141Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine.
Q91644477Integration of GWAS and brain eQTL identifies FLOT1 as a risk gene for major depressive disorder
Q91644471Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder
Q60305503Intraday Activity Levels May Better Reflect the Differences Between Major Depressive Disorder and Bipolar Disorder Than Average Daily Activity Levels
Q60915137Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study
Q37717808Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort
Q88815629Is familial risk for depression confounded by individual and familial socioeconomic factors and neighborhood environmental factors? A 7-year follow-up study in Sweden
Q90480293Kernel size-related genes revealed by an integrated eQTL analysis during early maize kernel development
Q38821961Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
Q52341028Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder.
Q91790213Mahuang-Fuzi-Xixin Decoction Reverses Depression-Like Behavior in LPS-Induced Mice by Regulating NLRP3 Inflammasome and Neurogenesis
Q56962426Major depressive disorder
Q26747013MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction
Q89898091Measurement and genetic architecture of lifetime depression in the Netherlands as assessed by LIDAS (Lifetime Depression Assessment Self-report)
Q92058771Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway
Q88674385Method to estimate the approximate samples size that yield a certain number of significant GWAS signals in polygenic traits
Q57697822Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples
Q39043211Methylomic profiling of cortex samples from completed suicide cases implicates a role for PSORS1C3 in major depression and suicide
Q93350625MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1
Q64255899Mineral Nutrition and the Risk of Chronic Diseases: A Mendelian Randomization Study
Q90776484Minimal phenotyping yields genome-wide association signals of low specificity for major depression
Q52370506Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression.
Q56976586Molecular genetic overlap between migraine and major depressive disorder
Q39043771Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies
Q39318173Mood, the Circadian System, and Melanopsin Retinal Ganglion Cells.
Q47945647Moving forward: how depression heterogeneity hinders progress in treatment and research
Q37695673Multivariate simulation framework reveals performance of multi-trait GWAS methods
Q27339187Nature and nurture: environmental influences on a genetic rat model of depression
Q28386468Neighborhood income and major depressive disorder in a large Dutch population: results from the LifeLines Cohort study
Q46300803Neuroimaging genomics in psychiatry-a translational approach
Q33602197Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence
Q37344755Neuropsychiatric genomics in precision medicine: diagnostics, gene discovery, and translation
Q38954644Pathogen-Host Defense in the Evolution of Depression: Insights into Epidemiology, Genetics, Bioregional Differences and Female Preponderance
Q26749017Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review
Q92760802Pathway-based polygene risk for severe depression implicates drug metabolism in CONVERGE
Q37686555Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women
Q47750361Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression.
Q92907278Pharmacogenetics and Depression: A Critical Perspective
Q42361493Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry
Q52630895Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.
Q36583679Polygenic interactions with environmental adversity in the aetiology of major depressive disorder.
Q45069030Polygenic risk for severe psychopathology among Europeans is associated with major depressive disorder in Han Chinese women
Q92957140Polygenic risk scores in schizophrenia with clinically significant copy number variants
Q33682211Possible association between SIRT1 single nucleotide polymorphisms and predisposition to antisocial personality traits in Chinese adolescents
Q88155978Predicting loneliness with polygenic scores of social, psychological and psychiatric traits
Q90268467Prediction of adolescent subjective well-being: A machine learning approach
Q47302028Predictive Psychiatric Genetic Testing in Minors: An Exploration of the Non-Medical Benefits
Q49536721Prepubertal Ovariectomy Exaggerates Adult Affective Behaviors and Alters the Hippocampal Transcriptome in a Genetic Rat Model of Depression.
Q89900613Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants
Q36059819Probing the stress and depression circuits with a disease gene
Q47147207Progress in Genetic Studies of Tourette's Syndrome
Q50546035Psychiatric genetics: what's new in 2015?
Q30362452Psychophysiology of threat response, paradigm shifts in psychiatry, and RDoC: Implications for genetic investigation of psychopathology.
Q57175641Psychotherapy and Genetic Neuroscience: An Emerging Dialog
Q37641087RETRACTED ARTICLE: 11,670 whole-genome sequences representative of the Han Chinese population from the CONVERGE project
Q37138536Rapid genotype imputation from sequence without reference panels
Q40519250Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.
Q40153548Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia
Q64884092Re-evaluating classical body type theories: genetic correlation between psychiatric disorders and body mass index.
Q92511862Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway
Q47171927Regulatory Pathways of Monoamine Oxidase A during Social Stress
Q90665100Regulatory mechanisms of major depressive disorder risk variants
Q37396696Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder
Q92982619Relationships among impulsive, addictive and sexual tendencies and behaviours: a systematic review of experimental and prospective studies in humans
Q47758383Repetitive transcranial magnetic stimulation inhibits Sirt1/MAO-A signaling in the prefrontal cortex in a rat model of depression and cortex-derived astrocytes
Q88536544Replicability and Prediction: Lessons and Challenges from GWAS
Q59790783Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population
Q42271275Resting-State Functional Connectivity-Based Biomarkers and Functional MRI-Based Neurofeedback for Psychiatric Disorders: A Challenge for Developing Theranostic Biomarkers.
Q37636582Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis.
Q64073926Reverse GWAS: Using genetics to identify and model phenotypic subtypes
Q91726009Risk Locus Identification Ties Alcohol Withdrawal Symptoms to SORCS2
Q40595654Risk factors and clinical characteristics of the depressive state induced by pegylated interferon therapy in patients with hepatitis C virus infection: A prospective study
Q57796699Robust Findings From 25 Years of PSTD Genetics Research
Q45072811Robust symptom networks in recurrent major depression across different levels of genetic and environmental risk
Q52592883Role and Possible Mechanisms of Sirt1 in Depression.
Q90433338SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts
Q37162737SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens.
Q91297787SIRT1 in forebrain excitatory neurons produces sexually dimorphic effects on depression-related behaviors and modulates neuronal excitability and synaptic transmission in the medial prefrontal cortex
Q57285505SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression
Q88770229SIRT1 rs3758391 and Major Depressive Disorder: New Data and Meta-Analysis
Q37622643SNP-based heritability estimates of the personality dimensions and polygenic prediction of both neuroticism and major depression: findings from CONVERGE.
Q90012640Sample Size for Successful Genome-Wide Association Study of Major Depressive Disorder
Q48048867Seeking an objective diagnosis of depression
Q39610291Serum proteomic profiles of depressive subtypes
Q96577383Sex differences in the genetic architecture of depression
Q37150882Sex-dependent adaptive changes in serotonin-1A autoreceptor function and anxiety in Deaf1-deficient mice
Q47641958Sex-specific transcriptional signatures in human depression
Q37510160Shared Genetics and Couple-Associated Environment Are Major Contributors to the Risk of Both Clinical and Self-Declared Depression
Q90170283Shared genetic etiology underlying Alzheimer's disease and major depressive disorder
Q89884949Shared genetic susceptibilities for irritable bowel syndrome and depressive disorder in Chinese patients uncovered by pooled whole-exome sequencing
Q58707338Sirtuins in Neuroendocrine Regulation and Neurological Diseases
Q26747309Somatic mutations in disorders with disrupted brain connectivity
Q40842173Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies
Q47136255Statistical methods to detect pleiotropy in human complex traits
Q35854307Substantial DNA methylation differences between two major neuronal subtypes in human brain
Q38687599Systems Genomics Support for Immune and Inflammation Hypothesis of Depression.
Q94558752TRPV6 variants confer susceptibility to chronic pancreatitis in the Chinese population
Q89747287Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder
Q57482794The 7q11.23 Protein DNAJC30 Interacts with ATP Synthase and Links Mitochondria to Brain Development
Q26766465The Adapting Mind in the Genomic Era
Q64071776The Antidepressant-like Effect of Flavonoids from Seeds in Chronic Restraint Stress Mice via Modulation of Monoamine Regulatory Pathways
Q37575275The Association of Genetic Predisposition to Depressive Symptoms with Non-suicidal and Suicidal Self-Injuries
Q30250052The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice
Q33866563The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder
Q98735784The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms
Q47745954The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder
Q38779701The Genetic Architecture of Major Depressive Disorder in Han Chinese Women
Q28396166The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders
Q37666098The Genetics-Driven Revival in Neuropsychiatric Drug Development.
Q40619240The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene
Q60046051The Mitochondrion as Potential Interface in Early-Life Stress Brain Programming
Q30854997The PHF21B gene is associated with major depression and modulates the stress response.
Q39305206The association of childhood maltreatment with depression and anxiety is not moderated by the oxytocin receptor gene.
Q39313687The brain, sirtuins, and ageing
Q52147506The cellular target of antidepressants.
Q45074070The centrality of DSM and non-DSM depressive symptoms in Han Chinese women with major depression
Q91825121The depression GWAS risk allele predicts smaller cerebellar gray matter volume and reduced SIRT1 mRNA expression in Chinese population
Q37613415The gender-specific association of rs334558 in GSK3β with major depressive disorder
Q48045533The genetic basis of the comorbidity between cannabis use and major depression
Q64091430The genetics of depression: successful genome-wide association studies introduce new challenges
Q91272520The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine
Q38659363The impact of epigenomic next-generation sequencing approaches on our understanding of neuropsychiatric disorders
Q38790294The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders
Q58450463The protein histidine phosphatase LHPP is a tumour suppressor.
Q39030396The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders
Q39246908The schizophrenia susceptibility gene ZNF804A confers risk of major mood disorders
Q35994785The successful search for genetic loci associated with depression
Q38676034The utility of empirically assigning ancestry groups in cross-population genetic studies of addiction
Q38446393Transcriptional profiling of mitochondria associated genes in prefrontal cortex of subjects with major depressive disorder
Q64071904Transcriptome Analysis on Maternal Separation Rats With Depression-Related Manifestations Ameliorated by Electroacupuncture
Q90659266Translating GWAS findings into therapies for depression and anxiety disorders: gene-set analyses reveal enrichment of psychiatric drug classes and implications for drug repositioning
Q45068646Transmission of alcohol use disorder across three generations: a Swedish National Study
Q37282393UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy
Q37223246Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression
Q64444724Uncovering the Genetic Architecture of Major Depression
Q90324756Unraveling the genetic architecture of major depressive disorder: merits and pitfalls of the approaches used in genome-wide association studies
Q26782991Using GWAS to identify genetic predisposition in hepatic autoimmunity
Q89939344Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population
Q90700111Very low-depth whole-genome sequencing in complex trait association studies
Q91895847Whole-Genome Sequencing Identifies the Egl Nine Homologue 3 (egln3/phd3) and Protein Phosphatase 1 Regulatory Inhibitor Subunit 2 (PPP1R2P1) Associated with High-Altitude Polycythemia in Tibetans at High Altitude
Q47955566Whole-genome single nucleotide variant distribution on genomic regions and its relationship to major depression
Q38443715Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity
Q40213493Widespread Allelic Heterogeneity in Complex Traits
Q34550161pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification
Q54957019β2-microglobulin induces depressive- and anxiety-like behaviors in rat.

Search more.